Patients face five-year wait for new drugs as NICE target slips
16 May 2012 | by Stephen Robinson
at the Alzheimer's Society, said GPs rely on NICE 'to remove ambiguity about a treatment and how it should be used ...
Showing 1 - 2 of 2 results
The Alzheimer's disease drug memantine improves cognitive function, but does not reduce clinically...Agitation is common in patients with Alzheimer s disease and can significantly affect their quality of life and that of their carers. Analysis of data from previous studies had suggested that memantine might reduce agitation, but this had not been studied in a prospective trial. Dr Chris Fox from ...
at the Alzheimer's Society, said GPs rely on NICE 'to remove ambiguity about a treatment and how it should be used ...
Sort results by: date | relevance
Click
to remove filters
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.